VBI Vaccines, Inc.VBI Vaccines, Inc.VBI Vaccines, Inc.

VBI Vaccines, Inc.

No trades
See on Supercharts
Market capitalization
‪18.02 M‬USD
‪−92.84 M‬USD
‪8.68 M‬USD
‪26.74 M‬
Beta (1Y)

About VBI Vaccines, Inc.

Jeffrey R. Baxter
Employees (FY)
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Revenue to profit conversion
Debt level and coverage
Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VBIV is 0.6337 USD — it has increased by 0.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange VBI Vaccines, Inc. stocks are traded under the ticker VBIV.
VBI Vaccines, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
VBIV stock is 7.45% volatile and has beta coefficient of 2.02. Check out the list of the most volatile stocks — is VBI Vaccines, Inc. there?
One year price forecast for VBI Vaccines, Inc. has a max estimate of 5.0000 USD and a min estimate of 5.0000 USD.
VBIV earnings for the last quarter are −0.38 USD per share, whereas the estimation was −0.14 USD resulting in a −171.43% surprise. The estimated earnings for the next quarter are −0.22 USD per share. See more details about VBI Vaccines, Inc. earnings.
VBI Vaccines, Inc. revenue for the last quarter amounts to ‪6.62 M‬ USD despite the estimated figure of ‪13.25 M‬ USD. In the next quarter revenue is expected to reach ‪5.36 M‬ USD.
Yes, you can track VBI Vaccines, Inc. financials in yearly and quarterly reports right on TradingView.
VBIV stock has risen by 6.70% compared to the previous week, the month change is a 8.45% rise, over the last year VBI Vaccines, Inc. has showed a 81.20% decrease.
VBIV net income for the last quarter is ‪−13.00 K‬ USD, while the quarter before that showed ‪−20.44 M‬ USD of net income which accounts for 99.94% change. Track more VBI Vaccines, Inc. financial stats to get the full picture.
Today VBI Vaccines, Inc. has the market capitalization of ‪18.02 M‬, it has increased by 31.57% over the last week.
No, VBIV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VBIV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VBI Vaccines, Inc. stock right from TradingView charts — choose your broker and connect to your account.
VBIV reached its all-time high on Aug 1, 2005 with the price of 59640.0000 USD, and its all-time low was 0.4500 USD and was reached on Oct 25, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 138.00 employees. See our rating of the largest employees — is VBI Vaccines, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VBI Vaccines, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VBI Vaccines, Inc. stock shows the sell signal. See more of VBI Vaccines, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VBI Vaccines, Inc. future price: according to them, VBIV price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Read a more detailed VBI Vaccines, Inc. forecast: see what analysts think of VBI Vaccines, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VBI Vaccines, Inc. EBITDA is ‪−52.67 M‬ USD, and current EBITDA margin is −614.16%. See more stats in VBI Vaccines, Inc. financial statements.